Japanese approval for Nycomed Pharma's surgical wound dressing:
This article was originally published in Clinica
Nycomed Pharma has received approval to market its TachoComb surgical wound dressing in Japan. When applied directly to a wound in organs such as the liver or lungs, the product's blood clotting factors and collagen fleece bond to stop diffuse bleeding and seal the tissue. Once the surgical wound has healed, the sealant resorbs into the body. TachoComb will be launched in Japan during the first quarter of 1999.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.